諾和諾德在中國(guó)諾和諾德是中國(guó)市場(chǎng)的領(lǐng)導(dǎo)者，一直以改變?yōu)榧喝巍ＶZ和諾德（中國(guó)）制藥有限公司于1994年成立，二十幾年來(lái)業(yè)務(wù)一直保持強(qiáng)勁增長(zhǎng)。公司總部設(shè)在北京，產(chǎn)品和服務(wù)遍及全國(guó)所有省、直轄市及中國(guó)港澳臺(tái)地區(qū)。截至2017年底，諾和諾德在華員工總數(shù)4329人。諾和諾德是在中國(guó)建立研發(fā)中心的生物制藥公司。位于北京的研發(fā)中心是諾和諾德全球研發(fā)體系的組成部分，致力于與總部合作研發(fā)新產(chǎn)品及新生產(chǎn)工藝。諾和諾德在中國(guó)的生產(chǎn)廠位于天津，是公司的國(guó)際化戰(zhàn)略生產(chǎn)基地。公司對(duì)工廠提供了大量的資金投入和技術(shù)支持，向全球以及中國(guó)市場(chǎng)供應(yīng)產(chǎn)品。諾和諾德在中國(guó)的不斷發(fā)展反映了公司對(duì)中國(guó)市場(chǎng)的承諾。Novo Nordisk in ChinaAs the leader in the Chinese market, Novo Nordisk has always been committed to Changing.Founded in 1994 and headquartered in Beijing, Novo Nordisk’s presence in China has been growing for more than 20 years.Headquartered in Beijing, providing products and services across mainland China as well as Hong Kong, Macau and of China. As of the end of 2017, Novo Nordisk employed over 4,329 employees in China.